Cost-Effectiveness Analysis of Iodine-123 Meta-Iodobenzylguanidine Imaging for Screening Heart Failure Patients Eligible for an Implantable Cardioverter Defibrillator in the USA
Crossref DOI link: https://doi.org/10.1007/s40258-016-0234-5
Published Online: 2016-03-14
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
O’Day, Ken
Levy, Wayne C.
Johnson, Meridith
Jacobson, Arnold F.
Funding for this research was provided by:
GE Healthcare
License valid from 2016-03-14